GENEVA, Feb. 18 -- DEWPOINT THERAPEUTICS, INC. (451 D Street, Suite 104Boston, MA 02210) filed a patent application (PCT/US2024/041552) for "IDENTIFYING COMPOUNDS THAT INDUCE A DESIRED PHENOTYPIC RESPONSE OF A CELL USING MACHINE LEARNING" on Aug 08, 2024. With publication no. WO/2025/035021, the details related to the patent application was published on Feb 13, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): PORTZ, Bede (c/o Dewpoint Therapeutics, Inc.451 D Street, Suite 104Boston, MA 02210), DUMOULIN, Etienne, Rene, Marie (c/o Dewpoint Therapeutics, Inc.451 D Street, Suite 104Boston, MA 022...